All In Biotech

Free tool

FAERS Monitor: Unithroid

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021210 or its brand name (Unithroid, Levothyroxine Sodium). Reports on generic versions are filed under their own applications.

Reports

102,450

Serious

70,776

69% of reports

Hospitalization

39,249

Death reported

8,406

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue8,376
  • nausea7,357
  • diarrhoea6,656
  • headache6,480
  • dyspnoea6,385
  • drug ineffective5,502
  • pain5,395
  • dizziness5,136
  • vomiting4,585
  • asthenia4,398
  • off label use4,180
  • fall4,153
  • malaise4,125
  • arthralgia4,026
  • pruritus3,519

Reports by year received

View as table
YearReports
20042,059
20052,025
20062,195
20072,773
20084,028
20093,842
20104,322
20116,155
20126,837
20131,415
20141,740
20152,411
20163,188
20173,647
20184,174
20194,062
20205,493
20215,861
20227,465
20237,039
20247,410
20258,338
20265,970

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,951,709 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
fallSignal4,1532.62.54,036
astheniaSignal4,3982.42.33,678
dyspnoeaSignal6,3852.32.34,927
fatigueSignal8,3762.22.25,780
headacheSignal6,4802.12.13,980
diarrhoeaSignal6,6562.12.14,065
dizzinessSignal5,1362.12.13,102
vomitingSignal4,5852.02.02,363
arthralgia4,0262.01.92,025
malaise4,1251.91.91,899
nausea7,3571.91.93,321
pruritus3,5191.91.81,483
pain5,3951.81.81,997
off label use4,1801.01.02
drug ineffective5,5020.90.8140

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.